Govt Orders Recall as Natco Cancer Drug Fails Toxin Test - Nanotechnology and Development News
|
Govt Orders Recall as Natco Cancer Drug Fails Toxin Test
Nanotechnology and Development News Tests showed that the drug, a nanotechnology-based generic version of a drug by the United States company Abraxis, could cause damage to the liver. … Author: n/aNanotechnology and Development News Big Opportunities in a Small WorldNanotechnology and Development News all 3 news articles » |
Posted under Uncategorized
This post was written by admin on July 24, 2009
